Hernandez-Cruz B, Otero-Varela L, Freire-Gonzalez M, Busquets-Perez N, et al. Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry. Ann Rheum Dis 2024 Apr 9:ard-2023-225271. doi: 10.1136/ard-2023-225271.
PMID: 38594056